ArticleCancer letters2024

Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers.

Angelina T Regua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.